RxDoctor Payments Data

David Dickoff, MD

Psychiatry · Yonkers, NYNPI 1548202484

Payments from drug & device makers

$112,192in general payments, 2019–2025

Across 921 payments — averaging $121.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$46K
  • Sanofi$25K
  • AbbVie$16K
  • MDD US Operations, LLC$4K
  • Takeda Pharmaceuticals U.S.A., Inc.$4K
  • Eisai Inc.$3K
  • plus $15K from 54 others

What the payments were for

  • Consulting fees$26,11523%
  • Speaking & faculty fees$53,74148%
  • Travel & lodging$10,92510%
  • Food & beverage$21,34919%
  • Education$620%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Acadia Pharmaceuticals Inc171$46,403
Sanofi53$24,552
AbbVie(2 entities)178$15,850
MDD US Operations, LLC32$3,867
Takeda Pharmaceuticals U.S.A., Inc.7$3,782
Eisai Inc.8$2,848
Boston Scientific13$1,991
Abbott12$1,795
Biogen43$1,341
Novartis46$984
Pfizer30$800
EMD Serono, Inc.36$691
Lundbeck LLC18$419
Kyowa Kirin, Inc.19$376
Lilly USA, LLC12$363
Grifols USA, LLC15$358
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)13$347
Catalyst Pharmaceuticals, Inc.11$310
Johnson & Johnson(2 entities)11$306
SK Life Science, Inc.14$303
UCB, Inc.11$279
Genentech USA, Inc.11$258
AstraZeneca6$249
Argenx US, Inc.9$221
Amgen(2 entities)9$219
Bristol Myers Squibb10$210
CSL Behring4$204
Medtronic2$199
Avion Pharmaceuticals10$193
Alnylam Pharmaceuticals Inc.8$181
Biohaven Pharmaceuticals, Inc.6$155
Idorsia Pharmaceuticals US Inc2$147
Biohaven Pharmaceutical Holding Company Ltd.6$142
Daiichi Sankyo Inc.6$134
Sunovion Pharmaceuticals Inc.7$126
E.r. Squibb & Sons, L.L.C.5$120
Amneal Pharmaceuticals LLC6$109
Neurocrine Biosciences, Inc.4$96
Mallinckrodt Enterprises LLC3$94
Tanabe Pharma America, Inc.4$87
Baxter Healthcare2$84
Almatica Pharma LLC3$78
Neurelis, Inc.4$78
Acorda Therapeutics, Inc4$74
TG Therapeutics, Inc.3$65
Xeris Pharmaceuticals, Inc.3$61
Akcea Therapeutics, Inc.3$59
Arbor Pharmaceuticals, Inc.3$50
Merz North America, Inc.2$47
Supernus Pharmaceuticals, Inc.3$45
Bardy Diagnostics, Inc.2$44
Adamas Pharmaceuticals, Inc.2$43
Teva Pharmaceuticals USA, Inc.2$40
Vertex1$35
Azurity Pharmaceuticals, Inc.1$28
Currax Pharmaceuticals LLC2$28
Otsuka America Pharmaceutical, Inc.1$28
Axsome Therapeutics, Inc.1$28
Corium, LLC1$28
Bausch Health US, LLC1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$112,192 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$214,804
Medicare patients
487
Services billed
1,614

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GammakedImmune Globul G/Gly/Iga Avg 4620$484,047
NuplazidPimavanserin Tartrate51$420,459
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5017$187,392
Kesimpta PenOfatumumab13$111,733
BotoxOnabotulinumtoxina29$41,079
RytaryCarbidopa/Levodopa19$31,448
Carbidopa-Levodopa ErCarbidopa/Levodopa494$31,085
NeuproRotigotine14$22,458
NamzaricMemantine Hcl/Donepezil Hcl12$16,998
Nurtec OdtRimegepant Sulfate17$16,375
Pramipexole DihydrochloridePramipexole Di-Hcl811$16,073
Divalproex Sodium ErDivalproex Sodium154$8,065
Nadolol83$5,502
Quetiapine Fumarate201$4,992
Bupropion XlBupropion Hcl185$4,671

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Acadia Pharmaceuticals IncNuplazid$46,403$420,45951 claims
Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid$3,782$187,39217 claims
AbbVieBotox, Namzaric$15,850$58,07741 claims
Amneal Pharmaceuticals LLCRytary$109$31,44819 claims
UCB, Inc.Neupro$279$22,45814 claims
PfizerNurtec Odt$800$16,37517 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Yonkers

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →